Oregon’s medical marijuana program admits to problems with MMJ oversight

Just Released! Get realistic market forecasts, state-by-state insights and benchmarks with the new 2024 MJBiz Factbook member program, now with quarterly updates. Make informed decisions.

The agency overseeing Oregon’s medical marijuana industry conceded in a report it has not provided effective oversight of growers and others in the industry, creating opportunities for cannabis to be diverted to the black market.

The blunt internal review echoes complaints from federal authorities that Oregon hasn’t adequately controlled its marijuana businesses and that overproduction of cannabis is feeding a black market in states that haven’t legalized it.

The review – requested by the Oregon Health Authority – showed there were more than 20,000 grow sites, but only 58 inspections were carried out in 2017.

The Oregon Medical Marijuana Program (OMMP) has far too few inspectors, while the tracking of growers and the cannabis they produce has been inadequate and inaccurate, the report concluded.

“Potentially erroneous reporting coupled with low reporting compliance makes it difficult to accurately track how much product is in the medical system,” the report said. “This limits OMMP’s ability to successfully identify and address potential diversion.”

Oregon Health Authority Director Patrick Allen ordered the internal review amid complaints from state and local law enforcement officials about lack of oversight of the marijuana industry.

The health authority directs the state’s Medical Marijuana Program, while the Liquor Control Commission regulates recreational cannabis.

The report said the medical marijuana oversight agency lacks reliable, independent tools to validate grow site locations and relies on inconsistent county databases.

Law enforcement authorities say they often have trouble identifying which marijuana growers are legal.

– Associated Press